Current Research
With our continued focus on the early detection of lung cancer, we have been able to expand our research efforts in the following areas:
- Developed a secure data base allowing us to register and track vital information from newly diagnosed lung cancer patients.
- Continued research support for Thymidine Kinase 1 (TK1) which included a presentation “Thymidine Kinase 1 Staining Aids in Lung Cancer Prognosis” at the 2011 American Association for Cancer Research Conference in Orlando, Florida. As part of this study, a variety of lung tumors were stained showing TK1 expression in the early stages of lung cancer with an increase in the TK1 expression as the cancer became more advanced.
- Expanded our funding to include Dr. Celine Mascaux, a highly qualified lung cancer researcher who is currently working under the direction of Dr. Fred Hirsch, MD, PhD, Professor of Medicine and Pathology at the University of Colorado Anschutz Medical Campus. Working in the Hirsch lab, Dr. Mascaux has been able to further test TK1 as a possible early detection biomarker and also continue independent research on other forms of early detection biomarkers for lung cancer.
